Article
Genomic Alteration in Metastatic Breast Cancer and Its Treatment
26 Mar 2020
Abstract excerpt
Metastatic breast cancer (mBC) remains responsible for the majority of breast cancer deaths. Whereas clinical outcomes have improved with the development of novel therapies, resistance almost inevitably develops, indicating the need for novel therapeutic approaches for the treatment of mBC. Recent investigations into mBC genomic alterations have revealed novel and potential therapeutic targets. Most notably,...
Topics
Join the communities discussing this publication.